291 related articles for article (PubMed ID: 12060400)
61. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
Stern RS; Lunder EJ
Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
[TBL] [Abstract][Full Text] [Related]
62. Cumulative solar ultraviolet radiation exposure and basal cell carcinoma of the skin in a nationwide US cohort using satellite and ground-based measures.
Little MP; Linet MS; Kimlin MG; Lee T; Tatalovich Z; Sigurdson AJ; Cahoon EK
Environ Health; 2019 Dec; 18(1):114. PubMed ID: 31881891
[TBL] [Abstract][Full Text] [Related]
63. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group.
Karagas MR; Stukel TA; Greenberg ER; Baron JA; Mott LA; Stern RS
JAMA; 1992 Jun; 267(24):3305-10. PubMed ID: 1597912
[TBL] [Abstract][Full Text] [Related]
64. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
Ortiz Salvador JM; Pérez-Ferriols A; Alegre de Miquel V; Saneleuterio Temporal M; Vilata Corell JJ
Med Clin (Barc); 2019 Jun; 152(12):488-492. PubMed ID: 30503067
[TBL] [Abstract][Full Text] [Related]
65. [Skin cancer incidence in Zacatecas].
Pinedo-Vega JL; Castañeda-López R; Dávila-Rangel JI; Mireles-García F; Ríos-Martínez C; López-Saucedo A
Rev Med Inst Mex Seguro Soc; 2014; 52(3):282-9. PubMed ID: 24878087
[TBL] [Abstract][Full Text] [Related]
66. Green tea protects against psoralen plus ultraviolet A-induced photochemical damage to skin.
Zhao JF; Zhang YJ; Jin XH; Athar M; Santella RM; Bickers DR; Wang ZY
J Invest Dermatol; 1999 Dec; 113(6):1070-5. PubMed ID: 10594754
[TBL] [Abstract][Full Text] [Related]
67. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
Henseler T; Christophers E; Hönigsmann H; Wolff K
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):108-16. PubMed ID: 3805379
[TBL] [Abstract][Full Text] [Related]
68. Hydrochlorothiazide Use and Skin Cancer: A Mohs Surgeon's Concern.
Cognetta AB; Wolfe CM; Heinrichs E
Dermatol Surg; 2016 Sep; 42(9):1107-9. PubMed ID: 27243134
[No Abstract] [Full Text] [Related]
69. Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013.
Rahmattulla C; Berden AE; Wakker SC; Reinders ME; Hagen EC; Wolterbeek R; Bruijn JA; Bajema IM
Arthritis Rheumatol; 2015 Dec; 67(12):3270-8. PubMed ID: 26246307
[TBL] [Abstract][Full Text] [Related]
70. Drug and chemical induced photosensitivity from a clinical perspective.
Ibbotson S
Photochem Photobiol Sci; 2018 Dec; 17(12):1885-1903. PubMed ID: 30283959
[TBL] [Abstract][Full Text] [Related]
71. p53 mutation in nonmelanoma skin cancers occurring in psoralen ultraviolet a-treated patients: evidence for heterogeneity and field cancerization.
Stern RS; Bolshakov S; Nataraj AJ; Ananthaswamy HN
J Invest Dermatol; 2002 Aug; 119(2):522-6. PubMed ID: 12190879
[TBL] [Abstract][Full Text] [Related]
72. Incidence of non-melanocytic skin cancer in Geraldton, Western Australia.
English DR; Kricker A; Heenan PJ; Randell PL; Winter MG; Armstrong BK
Int J Cancer; 1997 Nov; 73(5):629-33. PubMed ID: 9398037
[TBL] [Abstract][Full Text] [Related]
73. Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland.
Cantwell MM; Murray LJ; Catney D; Donnelly D; Autier P; Boniol M; Fox C; Middleton RJ; Dolan OM; Gavin AT
Br J Cancer; 2009 Jan; 100(1):174-7. PubMed ID: 19127269
[TBL] [Abstract][Full Text] [Related]
74. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
Lindelöf B
Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
[TBL] [Abstract][Full Text] [Related]
75. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.
Makhzoumi ZH; Arron ST
J Invest Dermatol; 2013 Aug; 133(8):1922-3. PubMed ID: 23856929
[TBL] [Abstract][Full Text] [Related]
76. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
[TBL] [Abstract][Full Text] [Related]
77. Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients.
Dybdahl M; Frentz G; Vogel U; Wallin H; Nexø BA
Mutat Res; 1999 Jan; 433(1):15-22. PubMed ID: 10047775
[TBL] [Abstract][Full Text] [Related]
78. Skin cancer in heart transplant recipients.
España A; Redondo P; Fernández AL; Zabala M; Herreros J; Llorens R; Quintanilla E
J Am Acad Dermatol; 1995 Mar; 32(3):458-65. PubMed ID: 7868716
[TBL] [Abstract][Full Text] [Related]
79. Squamous cell carcinoma of the scrotum.
Taniguchi S; Furukawa M; Kutsuna H; Sowa J; Ishii M
Dermatology; 1996; 193(3):253-4. PubMed ID: 8944352
[TBL] [Abstract][Full Text] [Related]
80. Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
deShazo R; Soltani-Arabshahi R; Krishnasamy S; Langley RG; Kalia S; Ståhle M; Langholff W; Goyal K; Fakharzadeh S; Galindo C; Srivastava B; Krueger G
J Drugs Dermatol; 2019 Oct; 18(10):1059-1060. PubMed ID: 31603636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
